|Articles|March 1, 2016
- Pharmaceutical Executive-03-01-2016
- Volume 36
- Issue 3
Pharmaceutical Executive, March 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
What Errors Do We Miss in Clinical Trials?over 9 years ago
Data Disclosure: Sealing the Error Envelopeover 9 years ago
Vaccines 2016: Big Bets for Global Threatsover 9 years ago
Drug Delivery Roundtable: More than the Pillover 9 years ago
Orphans of the Stormover 9 years ago
Country Report: The NetherlandsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
AbbVie Raises 2025 Profit Forecast Following Increased Demand for Immunology Treatments
2
Eli Lilly to Submit Oral GLP-1 for FDA Priority Review Program: Report
3
GCC Emerges as a New Strategic Anchor for Global Venture Capital
4
Pharmaceutical Executive Daily: Novo Nordisk's Unsolicited Acquisition Proposal
5
